Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults - PubMed (original) (raw)
Clinical Trial
Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults
K N Olivier et al. Am J Respir Crit Care Med. 1996 Jul.
Abstract
Impaired mucociliary clearance contributes to the pathophysiology of several airways diseases including cystic fibrosis, asthma, and chronic bronchitis. Extracellular triphosphate nucleotides (adenosine 5'-triphosphate [ATP], uridine 5'-triphosphate [UTP]) activate several components of the mucociliary escalator, suggesting they may have potential as therapeutic agents for airways diseases. We conducted initial (Phase I) studies of acute safety and efficacy of aerosolized UTP alone and in combination with aerosolized amiloride, the sodium channel blocker, in normal human volunteers. Safety was assessed by measurement of pulmonary function. Neither UTP alone nor in combination with amiloride caused any clinically significant adverse effects on airway mechanics, (subdivisions of) lung volumes, or gas exchange. Acute efficacy of UTP and amiloride alone and in combination, was assessed by measuring changes in the clearance of inhaled radiolabeled particles. A 2.5-fold increase in mucociliary clearance was seen in response to UTP alone and in combination with amiloride. We conclude that aerosolized UTP +/- amiloride clearly enhances mucociliary clearance without acute adverse effects in normal adults, and may have therapeutic potential to enhance airways clearance in diseases characterized by retained airways secretions.
Similar articles
- Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, Knowles MR. Bennett WD, et al. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1796-801. doi: 10.1164/ajrccm.153.6.8665037. Am J Respir Crit Care Med. 1996. PMID: 8665037 Clinical Trial. - A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, Boucher RC. Knowles MR, et al. N Engl J Med. 1990 Apr 26;322(17):1189-94. doi: 10.1056/NEJM199004263221704. N Engl J Med. 1990. PMID: 2157983 Clinical Trial. - Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
Bennett WD, Zeman KL, Foy C, Shaffer CL, Johnson FL, Regnis JA, Sannuti A, Johnson J. Bennett WD, et al. Am J Respir Crit Care Med. 2001 Jul 15;164(2):302-6. doi: 10.1164/ajrccm.164.2.2008094. Am J Respir Crit Care Med. 2001. PMID: 11463605 Clinical Trial. - Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
Knowles MR, Olivier K, Noone P, Boucher RC. Knowles MR, et al. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 2):S65-9. doi: 10.1164/ajrccm/151.3_Pt_2.S65. Am J Respir Crit Care Med. 1995. PMID: 7533608 Review. - [New aspects of therapy of mucoviscidosis (CF)].
Dietzsch HJ, Wunderlich P. Dietzsch HJ, et al. Kinderarztl Prax. 1993 Feb;61(1):19-23. Kinderarztl Prax. 1993. PMID: 8464194 Review. German.
Cited by
- Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease.
Centeio R, Ousingsawat J, Cabrita I, Schreiber R, Talbi K, Benedetto R, Doušová T, Verbeken EK, De Boeck K, Cohen I, Kunzelmann K. Centeio R, et al. Int J Mol Sci. 2021 Jul 22;22(15):7852. doi: 10.3390/ijms22157852. Int J Mol Sci. 2021. PMID: 34360618 Free PMC article. - Mucociliary Clearance in Mice Measured by Tracking Trans-tracheal Fluorescence of Nasally Aerosolized Beads.
Rogers TD, Ostrowski LE, Livraghi-Butrico A, Button B, Grubb BR. Rogers TD, et al. Sci Rep. 2018 Oct 3;8(1):14744. doi: 10.1038/s41598-018-33053-2. Sci Rep. 2018. PMID: 30282981 Free PMC article. - Duration of action of hypertonic saline on mucociliary clearance in the normal lung.
Bennett WD, Wu J, Fuller F, Balcazar JR, Zeman KL, Duckworth H, Donn KH, O'Riordan TG, Boucher RC, Donaldson SH. Bennett WD, et al. J Appl Physiol (1985). 2015 Jun 15;118(12):1483-90. doi: 10.1152/japplphysiol.00404.2014. Epub 2015 Apr 24. J Appl Physiol (1985). 2015. PMID: 25911685 Free PMC article. - Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.
Åstrand AB, Hemmerling M, Root J, Wingren C, Pesic J, Johansson E, Garland AL, Ghosh A, Tarran R. Åstrand AB, et al. Am J Physiol Lung Cell Mol Physiol. 2015 Jan 1;308(1):L22-32. doi: 10.1152/ajplung.00163.2014. Epub 2014 Oct 31. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 25361567 Free PMC article. - New pulmonary therapies directed at targets other than CFTR.
Donaldson SH, Galietta L. Donaldson SH, et al. Cold Spring Harb Perspect Med. 2013 Jun 1;3(6):a009787. doi: 10.1101/cshperspect.a009787. Cold Spring Harb Perspect Med. 2013. PMID: 23732851 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources